| Lastest Insider Transactions Of Intellia Therapeutics, Inc. ( NTLA ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2021-09-07 | Sell | 3,482 | 180.12 | 627,178 | 2021-09-09 17:38:46 |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2021-09-07 | Option Exercise | 3,482 | 14.58 | 50,768 | 2021-09-09 17:38:46 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2021-08-30 | Sell | 97,000 | 154.83 | 15,018,054 | 2021-09-01 19:34:46 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2021-08-30 | Option Exercise | 97,000 | 14.01 | 1,359,300 | 2021-09-01 19:34:46 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-08-19 | Sell | 22,682 | 151.28 | 3,431,398 | 2021-08-20 18:12:58 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-08-19 | Option Exercise | 22,682 | 13.40 | 303,939 | 2021-08-20 18:12:58 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2021-08-09 | Sell | 2,400 | 164.05 | 393,720 | 2021-08-11 16:50:08 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2021-08-09 | Option Exercise | 2,400 | 12.62 | 30,288 | 2021-08-11 16:50:08 |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Directior | 2021-06-28 | Sell | 553,376 | 132.73 | 73,448,880 | 2021-06-29 09:48:30 |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Directior | 2021-06-11 | Sell | 201,725 | 87.04 | 17,558,774 | 2021-06-15 09:51:28 |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Directior | 2021-04-29 | Sell | 4,513 | 85.43 | 385,546 | 2021-04-30 20:55:15 |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Directior | 2021-04-26 | Sell | 342,962 | 85.96 | 29,482,338 | 2021-04-28 19:51:49 |
| NTLA | Intellia Therapeutics, Inc. | DORSA CAROLINE | Directior | 2021-04-05 | Sell | 7,500 | 82.19 | 616,405 | 2021-04-06 18:09:59 |
| NTLA | Intellia Therapeutics, Inc. | DORSA CAROLINE | Directior | 2021-04-05 | Option Exercise | 7,500 | 6.40 | 48,000 | 2021-04-06 18:09:59 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-04-01 | Sell | 38,209 | 83.64 | 3,195,661 | 2021-04-02 20:46:42 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-04-01 | Option Exercise | 71,041 | 14.15 | 1,005,049 | 2021-04-02 20:46:42 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2021-04-01 | Sell | 50,455 | 82.46 | 4,160,559 | 2021-04-02 20:42:02 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2021-04-01 | Option Exercise | 97,001 | 12.51 | 1,213,537 | 2021-04-02 20:42:02 |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Directior | 2021-02-26 | Sell | 501,945 | 60.29 | 30,262,716 | 2021-03-01 13:59:47 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2021-02-09 | Sell | 11,489 | 75.00 | 861,675 | 2021-02-09 20:38:24 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2021-02-09 | Option Exercise | 21,000 | 18.30 | 384,195 | 2021-02-09 20:38:24 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-02-05 | Sell | 50,985 | 71.70 | 3,655,411 | 2021-02-09 20:36:01 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-02-05 | Option Exercise | 96,718 | 9.55 | 923,384 | 2021-02-09 20:36:01 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-02-01 | Sell | 177,745 | 67.26 | 11,955,395 | 2021-02-03 21:39:39 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-02-01 | Option Exercise | 317,060 | 15.16 | 4,807,393 | 2021-02-03 21:39:39 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2021-02-01 | Sell | 54,659 | 63.99 | 3,497,903 | 2021-02-03 21:38:12 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2021-02-01 | Option Exercise | 109,000 | 9.68 | 1,054,620 | 2021-02-03 21:38:12 |
| NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Directior | 2021-01-20 | Option Exercise | 20,000 | 13.78 | 275,600 | 2021-01-22 16:22:35 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-12-31 | Sell | 6,239 | 55.86 | 348,511 | 2021-01-05 21:24:58 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-12-31 | Option Exercise | 14,375 | 0.00 | 0 | 2021-01-05 21:24:58 |
| NTLA | Intellia Therapeutics, Inc. | SCHIERMEIER ANDREW | EVP, Chief Operating Officer | 2020-12-31 | Sell | 1,377 | 55.86 | 76,919 | 2021-01-05 20:58:21 |
| NTLA | Intellia Therapeutics, Inc. | SCHIERMEIER ANDREW | EVP, Chief Operating Officer | 2020-12-31 | Option Exercise | 4,792 | 0.00 | 0 | 2021-01-05 20:58:21 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-12-31 | Sell | 2,078 | 55.86 | 116,077 | 2021-01-05 20:55:19 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-12-31 | Option Exercise | 4,792 | 0.00 | 0 | 2021-01-05 20:55:19 |
| NTLA | Intellia Therapeutics, Inc. | SCHIERMEIER ANDREW | EVP, Chief Operating Officer | 2020-12-30 | Option Exercise | 1,500 | 13.48 | 20,220 | 2021-01-04 21:03:39 |
| NTLA | Intellia Therapeutics, Inc. | KARSEN PERRY A | Directior | 2020-12-17 | Sell | 88,764 | 53.55 | 4,753,680 | 2020-12-18 16:29:06 |
| NTLA | Intellia Therapeutics, Inc. | KARSEN PERRY A | Directior | 2020-12-17 | Option Exercise | 88,764 | 18.45 | 1,637,842 | 2020-12-18 16:29:06 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-12-01 | Sell | 3,364 | 38.21 | 128,525 | 2020-12-03 18:42:08 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-12-01 | Option Exercise | 5,000 | 13.88 | 69,400 | 2020-12-03 18:42:08 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-11-27 | Sell | 35,000 | 38.57 | 1,350,000 | 2020-11-27 21:00:41 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-11-27 | Option Exercise | 35,000 | 16.17 | 566,100 | 2020-11-27 21:00:41 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-11-25 | Sell | 50,000 | 36.00 | 1,800,000 | 2020-11-25 20:02:01 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-11-25 | Option Exercise | 50,000 | 6.83 | 341,500 | 2020-11-25 20:02:01 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-11-16 | Sell | 20,000 | 34.00 | 680,000 | 2020-11-18 19:56:27 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-11-16 | Option Exercise | 20,000 | 14.58 | 291,600 | 2020-11-18 19:56:27 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-11-16 | Sell | 6,653 | 34.36 | 228,568 | 2020-11-18 19:55:13 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-11-16 | Option Exercise | 11,410 | 8.25 | 94,103 | 2020-11-18 19:55:13 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-11-04 | Sell | 3,364 | 28.00 | 94,192 | 2020-11-06 16:41:02 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-11-04 | Option Exercise | 5,000 | 13.88 | 69,400 | 2020-11-06 16:41:02 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-11-04 | Sell | 50,000 | 26.00 | 1,300,000 | 2020-11-06 16:38:55 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-11-04 | Option Exercise | 50,000 | 6.83 | 341,500 | 2020-11-06 16:38:55 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-10-15 | Sell | 5,615 | 24.20 | 135,883 | 2020-10-16 20:58:05 |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | 2020-10-15 | Option Exercise | 10,000 | 6.83 | 68,300 | 2020-10-16 20:58:05 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-10-07 | Sell | 5,000 | 21.83 | 109,150 | 2020-10-09 16:14:15 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2020-10-07 | Option Exercise | 5,000 | 6.83 | 34,150 | 2020-10-09 16:14:15 |
